...While at GSK, Slaoui led the development of several vaccines, including Rotarix for infantile gastroenteritis, Synflorix...

...said the World Health Organization (WHO) gave prequalification to a 4-dose vial of pneumococcal vaccine Synflorix...
...the world's poorest countries. Local registration for the 4-dose vial in GAVI-supported countries is ongoing. Synflorix...
...derived protein D. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix) Business: Infectious Allison Johnson Synflorix GlaxoSmithKline...

...use of Synflorix vaccine against pneumococcal disease, and said GSK is cutting the price of Synflorix...

...Japan approved Synflorix to prevent invasive infectious diseases and pneumonia caused by pneumococcus in infants. Synflorix...
...Tokyo, Japan), a 50/50 JV between GSK and Daiichi Sankyo Co. Ltd. (Tokyo:4568, Tokyo, Japan). Synflorix...
...protein Haemophilus influenzae-derived protein D. GlaxoSmithKline pl c (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...

...developing countries for five years after each country graduates from GAVI support. GSK provides its Synflorix...

...Tokyo, Japan) submitted an application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Synflorix...
...against invasive disease and acute otitis media caused by S. pneumoniae in the age group. Synflorix...
...carrier protein Haemophilus influenzae-derived protein D. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...

...The European Commission approved an expanded label for Synflorix vaccine from GlaxoSmithKline to include vaccination against...
...against invasive disease and acute otitis media caused by S. pneumoniae in the age group. Synflorix...
...carrier protein Haemophilus influenzae-derived protein D. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...

...EMA's CHMP issued a positive opinion recommending expanding the label of Synflorix vaccine from GlaxoSmithKline to...
...in the age group. GSK expects a final decision from the European Commission this quarter. Synflorix...
...carrier protein Haemophilus influenzae-derived protein D. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...

...steps include developing a multivalent version of the vaccine targeting other bacterial antigens. GlaxoSmithKline plc's Synflorix...

...2+1 dosing schedule of Synflorix vs. 12 cases in children receiving hepatitis vaccines as controls. Synflorix...
...GSK said it plans to submit the data to regulatory authorities for inclusion in the Synflorix...
...Data were published in The Lancet. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...